BOSTON – The CEO of a microcap company that claimed to own
valuable patented drug delivery technology was sentenced today in federal court
in Boston in connection with a scheme to manipulate the market for his
company’s publicly traded stock.
Learned Jeremiah Hand, 59, of Durham, N.C., was sentenced by
U.S. District Court Chief Judge Patti B. Saris to nine months in prison and one
year of supervised release, with restitution to be determined at a later date.
In August 2016, Hand pleaded guilty to conspiracy to commit securities fraud.
In May 2018, his brother, Jehu Hand, 61, was convicted by a federal jury of
conspiracy, securities fraud and wire fraud, and he is scheduled to be
sentenced on Oct. 25, 2018. Their other brother, Adam Hand, 53, of Newport
Beach, Calif., was sentenced to 30 months in prison and three years of
supervised release after pleading guilty to one count of conspiracy to commit securities
fraud.
The Hand brothers conspired in a pump-and-dump scheme to
manipulate the market for the stock of Crown Marketing, a microcap or “penny
stock” company that claimed to own valuable patented drug delivery technology.
Specifically, Learned Hand and his brothers engaged in a scheme to conceal
their control over the majority of Crown’s free-trading stock so that they
could “pump” up the company’s share price and then secretly “dump” their shares
into the market. Jehu Hand filed false registration statements with the
Securities and Exchange Commission (SEC) so that the stock that the
co-conspirators controlled could be sold to the public. Meanwhile, Learned
Hand, who had been named Crown’s CEO, orchestrated a press campaign, including
the distribution of press releases containing false and misleading statements
regarding the drug delivery technology purportedly owned by Crown. Crown’s
share price and trading volume shot up as a result of the hype created by the
false press, and the co-conspirators, including Adam Hand, then proceeded to
sell millions of shares of Crown stock to unwitting investors at inflated
prices.
United States Attorney Andrew E. Lelling and Harold H. Shaw,
Special Agent in Charge of the Federal Bureau of Investigation, Boston Field
Division, made the announcement today.
The United States Attorney’s Office received valuable assistance from
the Securities & Exchange Commission and Financial Industry Regulatory
Authority during the investigation of this matter. Assistant U.S. Attorney Jamie Herbert of
Lelling’s Criminal Division and SEC Attorney Andrew Palid, who was appointed as
a Special Assistant U.S. Attorney, prosecuted case.
No comments:
Post a Comment